Skip to content

TuHURA Biosciences, Inc. HURA Acquisition and integration costs

Acquisition and integration costs at other companies

Peabody Energy logo
Peabody EnergyBTU
$3M+25.0%
KEE
Keel Infrastructure Corp. Common StockKEEL
$1.77M
Q2 Holdings logo
Q2 HoldingsQTWO
$250K
Construction Partners logo
Construction PartnersROAD
$2.48M+208%
ATN International logo
ATN InternationalATNI
$833K-42.0%
FIP
FTAI Infrastructure Inc.FIP
$6.82M+94.0%

Other financials

Income statement

See full
Revenue-
Net income-$7.5M-13.1%
EPS (diluted)-$0.13+13.3%

Balance sheet

See full
Cash & equivalents$6.3M+1.3%
Total debt$456.9K+178%
Total equity$23.2M+135%
Total assets$29.7M+103%

Cash flow

See full
Operating cash flow-$4.4M+6.9%
CapEx$48.8K+14.5%
Free cash flow-$4.5M+6.7%

Valuation

See full
Market cap$155.39M+45.8%
Enterprise value$149.54M+52.3%

Returns & leverage

See full
Return on equity-187.2%
Debt / equity0.0×
Current ratio1.2×-1.8×

Where this comes from

Reported directly by TuHURA Biosciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:BusinessCombinationAcquisitionRelatedCosts.

The official record: TuHURA Biosciences, Inc.’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about TuHURA Biosciences, Inc.'s acquisition and integration costs.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is TuHURA Biosciences, Inc.'s acquisition and integration costs?
TuHURA Biosciences, Inc. (HURA) reported acquisition and integration costs of $419.04K in Q1 2025.
How has TuHURA Biosciences, Inc.'s acquisition and integration costs changed year-over-year?
TuHURA Biosciences, Inc.'s acquisition and integration costs increased by 280.7% year-over-year, from $110.09K to $419.04K.
What does acquisition and integration costs mean?
Represents the direct costs incurred in connection with business combinations, including legal, advisory, and integration expenses. These costs reflect the financial impact of expanding corporate operations through M&A activity rather than organic growth. Investors monitor these to assess the efficiency of inorganic growth strategies and the impact of non-recurring transaction expenses on operating margins.